4
Changes in Ownership
Pyxis Oncology, Inc. Filed Acc 0001209191-23-060006
Options or other derivatives
- Chief Medical Officer acquired 554,392 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kobayashi Ken · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-29 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +443,514 | 443,514 | D |
| 2023-12-29 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +110,878 | 110,878 | D |
Loading xslF345X05/doc4.xml…